Filters
|
|
| |||
863 of 863 products, sorted A-Z
|
||||
3.8 ★★★★ ☆ (8) |
7Acres |
| THC | 220 - 280mg/g (25%) | THC MEDIUM | 0 - 20mg/g (1.0%) | CBD |
| eweed.pro | INDICA | csmeter © | ||
| $ –.– – |
3.5g | $0.00/g |
Woody 5/10 |
AROMA / FLVR |
||
+Pine 4 |
+Spice 3 |
||
Arthritis 5/10 |
AID** WITH |
||
+Pain 4 |
+Sleep 4 |
||
| Potency | THC Medium | |
| THC | 220-280mg/g | 25% |
| CBD | 0-20mg/g | 1.0% |
| Plant | Indica Dominant | |
| Strain(s) | Tom Ford Island Pink | |
| Grown In | British Columbia | |
| Method | INDOOR | |
| Brand | 7Acres by Canopy Growth | |
| GTIN# |
00628242510905 (3.5g) |
|
|
Terpenesⓘ
|
Beta-Pinene, Caryophyllene, Humulene, Limonene, Linalool | |
7ACRES Craft Collective selected this particular Pink Kush for its intensely pungent fuel notes, high THC and rock-hard density. A terpene rich indica dominant hybrid that fills the room with heavy diesel notes and hints of flowery perfume and citrus.
7ACRES takes pride in growing High End CannabisTM that respects each cultivar’s genetic lineage and history. They are committed to providing enthusiasts with hand-crafted cannabis flower that delivers an uncompromised experience. 7ACRES products are crafted by knowledgeable cannabis minds, who share a passion for the product; from seed, to shelf, and into consumers hands.
Every effort is made to ensure that each harvest is greater than the last and celebrated with better aroma and flavour.
About Canopy Growth
Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.
With operations spanning fifteen countries across five continents, Canopy Growth Corporation is a world-leading diversified cannabis company proudly dedicated to educating healthcare practitioners, advancing the public discourse surrounding cannabis, and conducting robust clinical research in cannabinoid-based animal and human medicines.
| 1.0 ★ ☆☆☆☆ |
THX | Aug-22 |
| 4.0 ★★★★ ☆ |
Danaus | Oct-19 |
| 5.0 ★★★★★ |
Saman | Oct-18 |